1 / 33

Jim Potter Malcolm Brock

Jim Potter Malcolm Brock. Biospecimen Collection and Processing.

berk-hoover
Télécharger la présentation

Jim Potter Malcolm Brock

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Jim PotterMalcolm Brock Biospecimen Collection and Processing

  2. “To wrest from nature the secrets which have perplexed philosophers in all ages, to track to their sources the causes of disease, to correlate the vast stores of knowledge, that they are quickly available for the prevention and cure of disease – these are our ambitions.” - Sir William Osler, 1906 Biobanks: Collaborating for Cures

  3. Clinical Research Translational Research Basic Research Clinical Research Tissue Repository Repository CaTissue DB Registry/Database CRMS DB • Roles: • Best Practices/SOP • Tissue Processing • Tissue Storage • Management of Tissues • Distribution of Tissues • Roles: • Pt Identification • Pt Recruitment • Facilitate Clinical Trials, • Translational and Basic Research • Support of Patient Registry and Database

  4. Specimen Collection: Factors to be considered: • Purpose of the Biorepository • Best Practices / SOPs • Consent • Governance / Oversight • Funding Support • Hardware • Software/Audit/Security • Personnel (FTE)

  5. Purpose of the Biorepository: • To formalize thecollectionof all specimensfollowing Best Practices (BP) and Standard Operating Procedures (SOPs) • The Informal collection of specimens stored in Investigator’s freezer should be avoided.

  6. Specimen Collection: Factors to be considered: • Purpose of the Biorepository • Best Practices / SOPs • Consent • Governance / Oversight • Funding Support • Hardware • Software/Audit/Security • Personnel (FTE)

  7. NCI / ISBER Guidelines for Biorepository Best Practices • Biospecimen collection • Biospecimen processing and annotation • Biospecimen storage and distribution • Quality assurance and standardization • Bioinformatics and data management • Ethical concerns • Intellectual property and legal issues • Outreach, patient education and post-research communication

  8. Specimen Collection: Factors to be considered: • Purpose of the Biorepository • Best Practices / SOPs • Consent • Governance / Oversight • Funding Support • Hardware • Software/Audit/Security • Personnel (FTE)

  9. Informed Consent: • Restricted or tiered consent • Specimen use limited to study design or disease state • Specimen use may be limited to tenure of the investigator • General consent • Maximizes scientific utility of the repository • Promotes valuable new science

  10. Specimen Collection: Factors to be considered: • Purpose of the Biorepository • Best Practices / SOPs • Consent • Governance / Oversight • Funding Support • Hardware • Software/Audit/Security • Personnel (FTE)

  11. Biorepository: Oversight Committee • Provide ethical oversight of all research involving repository specimens • Assure the best possible biospecimen quality • BP are followed • SOP Manual reviewed, updated and followed

  12. Oversight Committee • Provide consistent documentation • Establish guidelines for collection, processing, storage and retrieval of specimens • Assessment of new technologies and the incorporation of new technologies into the repository • Assure the fair and impartial utilization of specimen resources

  13. Oversight Committee Access decisions guided by a set of general principles defined in the NCI Best Practices including: • Investigator agreement covering confidentiality, use, disposition, and security of biospecimens and associated data. • Timely, equitable, and appropriate access to specimens • Fair and clearly communicated access procedures • Scientific merit with institutional research qualifications, and a research plan appropriate to answer the study questions • An appeals process for addressing disputes over allocation decisions Federal Register / Vol. 71, No. 82 / Friday, April 28, 2006. First-Generation Guidelines for NCI Supported Biorepositories

  14. Core Center PI - Mark Donowitz • Directors - Jim Potter, Steve Brant • One PI from each of “8 study sections” • At least two rotatingindependentnon-GI, JHU investigators (Geneticist, Bioethicist) Oversight Committee Example: GI-TxB Oversight Committee Division Director Anthony Kalloo

  15. Specimen Collection: Factors to be considered: • Purpose of the Biorepository • Best Practices / SOPs • Consent • Governance / Oversight • Funding Support • Hardware • Software/Audit/Security • Personnel (FTE)

  16. Funding • Grants • Divisional Support • Charge Back Scheme by Biorepository Core • Donation of Specimens to Biorepository Core

  17. Specimen Collection: Factors to be considered: • Purpose of the Biorepository • Best Practices / SOPs • Consent • Governance / Oversight • Funding Support • Hardware • Software/Audit/Security • Personnel (FTE)

  18. Hardware: • Cryofreezer (N2 vapor ) • -80˚C freezer • -20˚C freezer • 4˚C Refrigerator • Freezer Monitoring System • alarmed to FTE Cell phone • internet accessible • N2 vapor transport system • Barcoding • Centrifuges • Cryostat

  19. Specimen Collection: Factors to be considered: • Purpose of the Biorepository • Best Practices / SOPs • Consent • Governance / Oversight • Funding Support • Hardware • Software/Audit/Security • Personnel (FTE)

  20. Tissue Bank Database Software • CaTissue DB Software – NCI Open Source software established through caBig (Cancer Biomedical Informatics Grid) • Pilot Projects: • James Cassella – Sickle Cell Disease Multi-Institutional – 3 sites • Richard Roden – Cervical Cancer SPORE • Jim Potter, Steve Brant - IBD

  21. caTissue Suite: • Core Functions / Modules • Administration: Create and edit users, protocols, and storage systems associated with a biospecimen inventory. • Biospecimen: Create and edit data concerning participants and their corresponding biospecimens. • Query: Identify biospecimens and their data based upon one or more selection criteria.

  22. Key Functions and Benefits of caTissue Suite • Search • Allows biospecimen resource staff and scientists alike to search for biospecimens based on a combination of properties • Biospecimen Tracking • Allows biospecimen resource staff to record events related to biospecimen processing and quality assurance and to annotate biospecimens with pathological, clinical, and custom data • Biospecimen Inventory Management • Allows biospecimen resource staff to record data about biospecimen collection, storage, requests, and distribution.

  23. caTissue - Benefits For University • centralized application • no licensing fees (Open Source) • HIPAA compliance easy to monitor • Data Security and Integrity For PIs: • No need for custom databases • Easier data sharing • Improved data organization • HL7 importing of data

  24. caTissue Pilots: Pilot approach • Install caTissue and provide training • Migrate pilot tissue banking data to caTissue • Integrate with JHM systems (ADT, eIRB, CRMS • Customize for non-cancer tissue banks • Extend to handle data elements not in caTissue • Bug fixes/ maintenance during pilot period • Funding in place to hire group to extend and support caTissue

  25. Specimen Collection: Factors to be considered: • Purpose of the Biorepository • Best Practices / SOPs • Consent • Governance / Oversight • Funding Support • Hardware • Software/Audit/Security • Personnel (FTE)

  26. Personnel FTE role • Cataloging, storing, removal and processing of tissues • Supervision and training of FTEs directly receiving tissues from patients to assure Best Practices. Best Practice: All FTEs responsible for tissue procurement should be directed by the tissue repository administration

  27. Specimen Collection FTE • Procure via Best Practices & SOP • Specimen ID (barcode) • Preserve specimen • Transportation to the Tissue Bank • Register specimen ID (barcode) in database • Process the specimen, if required (blood, RNA, DNA, etc.) • Storage • Archive

  28. Systematic BioSpecimen Collection for Personalized Cancer Medicine at Johns Hopkins Medical Institutes (Robotic Biospecimen Storage Facility)

  29. Blood specimen processing and cryopreservation

  30. Tumor and control tissue cryopreservation

  31. Specimen Processing: • Would you use a Specimen Processing Service? • Research Phlebotomist Services and possibly • processing capability can be purchased.

  32. References: • Best Practices for Repositories I: collection, storage and retrieval of human biological materials for research, ISBER. Cell Preservation Technology; Volume3, Number1, 2005, Update 2008. • National Cancer Institute, Best Practices for Biospecimen Resources 2007 • Case Studies of Human Tissue Repositories; Best Practices for a Biospecimen Resource for the Genomic and Proteomic Era. RAND Scientific Corporation, prepared for the National Cancer Institute. http://biospecimens.cancer.gov/nbn/rand.asp

  33. References: • Cancer Bioinformatics Grid, caBIG: https://cabig.nci.nih.gov/. • First Generation Guidelines for NCI Supported Biorepositories:http://biospecimens.cancer.gov/biorepositories/NCI-Supported_Biorepositories.pdf • Federal Register / Vol. 71, No. 82 / Friday, April 28, 2006. First-Generation Guidelines for NCI Supported Biorepositories

More Related